Lupus like syndrome drugs

Drug-induced lupus (DIL) is an under-recognized disorder. It results from medications that induce production of autoantibodies and a lupus-like syndrome.

Drug-induced lupus erythematosus is an uncommon, mild to moderately severe, a lupus-like syndrome related in time to continuous exposure to a specific

Conditions that require immunosuppressive drugs include skin diseases such as pemphigus, pemphigoid, and lupus-like syndromes.

Drug-induced lupus is a syndrome which share symptoms and laboratory characteristics with idiopathic systemic lupus erythematosus (SLE). The terms drug-induced lupus (DIL) and drug-induced lupus erythematosus (DILE) are preferred, but other ones are also used-drug-related lupus, lupus-like syndrome

Through various mechanisms, some drugs may give lupus-like syndromes as a side effect. They may activate a latent lupus or cause a separate

Drug-induced lupus erythematosus is an uncommon, mild to moderately severe, a lupus-like syndrome related in time to continuous exposure to a specific

Some researchers rely on the presence of specific autoantibodies to make a distinction of lupus-like syndrome from vasculitis like syndrome. 7,10,11 However, it is quite often that drug-induced vasculitis cannot be clearly distinguished from lupus-like syndrome. 4 6,8 It has been described that repeated treatment with antithyroid agents and

Drug-induced lupus erythematosus (DIL) is a subset of lupus defined as a lupus-like syndrome that develops in temporal relation to exposure to a drug.

OBJECTIVE Each TNF-αinhibitor (TNFi) can induce lupus or lupus-like syndrome. Nevertheless, the risk may differ between drugs because of